TY - JOUR
T1 - Inhibition of transient receptor potential cation channel 6 promotes capillary arterialization during post-ischaemic blood flow recovery
AU - Numaga-Tomita, Takuro
AU - Shimauchi, Tsukasa
AU - Kato, Yuri
AU - Nishiyama, Kazuhiro
AU - Nishimura, Akiyuki
AU - Sakata, Kosuke
AU - Inada, Hiroyuki
AU - Kita, Satomi
AU - Iwamoto, Takahiro
AU - Nabekura, Junichi
AU - Birnbaumer, Lutz
AU - Mori, Yasuo
AU - Nishida, Motohiro
N1 - Funding Information:
This work was supported by JST, Core Research for Evolutional Science and Technology Grant Number JPMJCR2024 (20348438); Japan Society for the Promotion of Science Grant Numbers 19K07116, 19H03383, 21H05269, 22H02772, 22H04814, and 22K06842; Japan Agency for Medical Research and Development (JP22ama121031); and Smoking Research Foundation. This work was also supported by Cooperative Study Program of National Institute for Physiological Sciences and Advanced Bioimaging Support (ABiS) and by the National Research Foundation of Korea (NRF) funded by the Korean Government (MSIP) (2017K1A1A2004511).
Publisher Copyright:
© 2022 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
PY - 2023/1
Y1 - 2023/1
N2 - Background and Purpose: Capillary arterialization, characterized by the coverage of pre-existing or nascent capillary vessels with vascular smooth muscle cells (VSMCs), is critical for the development of collateral arterioles to improve post-ischaemic blood flow. We previously demonstrated that the inhibition of transient receptor potential 6 subfamily C, member 6 (TRPC6) channels facilitate contractile differentiation of VSMCs under ischaemic stress. We here investigated whether TRPC6 inhibition promotes post-ischaemic blood flow recovery through capillary arterialization in vivo. Experimental Approach: Mice were subjected to hindlimb ischaemia by ligating left femoral artery. The recovery rate of peripheral blood flow was calculated by the ratio of ischaemic left leg to non-ischaemic right one. The number and diameter of blood vessels were analysed by immunohistochemistry. Expression and phosphorylation levels of TRPC6 proteins were determined by western blotting and immunohistochemistry. Key Results: Although the post-ischaemic blood flow recovery is reportedly dependent on endothelium-dependent relaxing factors, systemic TRPC6 deletion significantly promoted blood flow recovery under the condition that nitric oxide or prostacyclin production were inhibited, accompanying capillary arterialization. Cilostazol, a clinically approved drug for peripheral arterial disease, facilitates blood flow recovery by inactivating TRPC6 via phosphorylation at Thr69 in VSMCs. Furthermore, inhibition of TRPC6 channel activity by pyrazole-2 (Pyr2; BTP2; YM-58483) promoted post-ischaemic blood flow recovery in Apolipoprotein E-knockout mice. Conclusion and Implications: Suppression of TRPC6 channel activity in VSMCs could be a new strategy for the improvement of post-ischaemic peripheral blood circulation.
AB - Background and Purpose: Capillary arterialization, characterized by the coverage of pre-existing or nascent capillary vessels with vascular smooth muscle cells (VSMCs), is critical for the development of collateral arterioles to improve post-ischaemic blood flow. We previously demonstrated that the inhibition of transient receptor potential 6 subfamily C, member 6 (TRPC6) channels facilitate contractile differentiation of VSMCs under ischaemic stress. We here investigated whether TRPC6 inhibition promotes post-ischaemic blood flow recovery through capillary arterialization in vivo. Experimental Approach: Mice were subjected to hindlimb ischaemia by ligating left femoral artery. The recovery rate of peripheral blood flow was calculated by the ratio of ischaemic left leg to non-ischaemic right one. The number and diameter of blood vessels were analysed by immunohistochemistry. Expression and phosphorylation levels of TRPC6 proteins were determined by western blotting and immunohistochemistry. Key Results: Although the post-ischaemic blood flow recovery is reportedly dependent on endothelium-dependent relaxing factors, systemic TRPC6 deletion significantly promoted blood flow recovery under the condition that nitric oxide or prostacyclin production were inhibited, accompanying capillary arterialization. Cilostazol, a clinically approved drug for peripheral arterial disease, facilitates blood flow recovery by inactivating TRPC6 via phosphorylation at Thr69 in VSMCs. Furthermore, inhibition of TRPC6 channel activity by pyrazole-2 (Pyr2; BTP2; YM-58483) promoted post-ischaemic blood flow recovery in Apolipoprotein E-knockout mice. Conclusion and Implications: Suppression of TRPC6 channel activity in VSMCs could be a new strategy for the improvement of post-ischaemic peripheral blood circulation.
UR - http://www.scopus.com/inward/record.url?scp=85139171307&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85139171307&partnerID=8YFLogxK
U2 - 10.1111/bph.15942
DO - 10.1111/bph.15942
M3 - Article
C2 - 36068079
AN - SCOPUS:85139171307
SN - 0007-1188
VL - 180
SP - 94
EP - 110
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 1
ER -